Sign in
Decitabine therapy in patients with AML or MDS and chromosome 5, 7, or 8 abnormalities
Journal article   Peer reviewed

Decitabine therapy in patients with AML or MDS and chromosome 5, 7, or 8 abnormalities

S. R. Mohan, M. A. Sekeres, Y. Saunthararajah and J. P. Maciejewski
Journal of clinical oncology, Vol.28(15_suppl), pp.6555-6555
2010-05-20

Metrics

1 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

undefined

Source: InCites

Details